Drug combination
Hydroxychloroquine and azithromycin was to have been the focus of a nationwide clinical trial enrolling 2,000 participants, but that study has been called off. (UW Medicine Photo)

The National Institute of Allergy and Infectious Diseases has shut down a clinical trial to see if a combination of hydroxychloroquine and azithromycin can prevent hospitalization and death due to COVID-19.

Like what you're reading? Subscribe to GeekWire's free newsletters to catch every headline

Job Listings on GeekWork

Find more jobs on GeekWork. Employers, post a job here.